Evidence map›Paper›PMID 39034312›Full record

ArticleNature communications2024

Glutathione synthesis in the mouse liver supports lipid abundance through NRF2 repression.

Gloria Asantewaa, Emily T Tuttle, Nathan P Ward, Yun Pyo Kang, Yumi Kim, Madeline E Kavanagh, Nomeda Girnius, Ying Chen, Katherine Rodriguez, Fabio Hecht and 28 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Antioxidants (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Inflammatory CD4iScience · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

38 authors.

Gloria AsantewaaDepartment of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, NY, USA.ORCID 0000-0002-1420-4448
Emily T TuttleDepartment of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.
Nathan P WardDepartment of Metabolism and Physiology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.ORCID 0000-0003-4920-0081
Yun Pyo KangDepartment of Metabolism and Physiology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.ORCID 0000-0002-1149-0880
Yumi KimDepartment of Metabolism and Physiology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.ORCID 0000-0001-8815-3121
Madeline E KavanaghDepartment of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA, USA.
Nomeda GirniusDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-7267-5950
Ying ChenDepartment of Environmental Health Sciences, Yale School of Public Health, New Haven, CT, USA.
Katherine RodriguezDepartment of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.
Fabio HechtDepartment of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.ORCID 0000-0001-9110-2587
Marco ZocchiDepartment of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.
Leonid Smorodintsev-SchillerDepartment of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.
TashJaé Q ScalesDepartment of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.
Kira TaylorDepartment of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.
Fatemeh AlimohammadiWilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
Renae P DuncanCenter for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY, USA.ORCID 0000-0001-6897-3755
Zachary R SechristWilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
Diana Agostini-VulajDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA.ORCID 0000-0002-3847-0302
Xenia L SchaferDepartment of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, NY, USA.
Hayley ChangDepartment of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.
Zachary R SmithDepartment of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.
Thomas N O'ConnorDepartment of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.
Sarah WhelanLeicester Cancer Research Centre, University of Leicester, Leicester, UK.
Laura M SelforsDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-1317-7353
Jett CrowdisDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA.
G Kenneth GrayDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-4969-670X
Roderick T BronsonDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA.
Dirk BrennerExperimental and Molecular Immunology, Dept. of Infection and Immunity (DII), Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.ORCID 0000-0001-8979-1045
Alessandro RufiniLeicester Cancer Research Centre, University of Leicester, Leicester, UK.ORCID 0000-0002-5855-655X
Robert T DirksenDepartment of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, NY, USA.ORCID 0000-0002-3182-1755
Aram F HezelDepartment of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.
Aaron R HuberDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Joshua MungerDepartment of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, NY, USA.ORCID 0000-0001-5379-9440
Benjamin F CravattDepartment of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA, USA.ORCID 0000-0001-5330-3492
Vasilis VasiliouDepartment of Environmental Health Sciences, Yale School of Public Health, New Haven, CT, USA.ORCID 0000-0003-2552-3118
Calvin L ColeWilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
Gina M DeNicolaDepartment of Metabolism and Physiology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.ORCID 0000-0001-6611-6696
Isaac S HarrisDepartment of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA. isaac_harris@urmc.rochester.edu.ORCID 0000-0002-6855-2763

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI John L. Cleveland · 1998 to 2026
$93.5M
Mouse Models for Alcohol Metabolism and Tissue InjuryR24AA022057 · NIAAA · YALE UNIVERSITY · PI VASILIOU, VASILIS · 2013 to 2022
$4.5M
Investigation of NRF2-Dependent Metabolic LiabilitiesR37CA230042 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI DENICOLA, GINA MARIE · 2018 to 2024
$2.8M
Pathophysiology and Treatment of Recessive RYR1 Related MyopathyR01AR078000 · NIAMS · UNIVERSITY OF ROCHESTER · PI JAMES J DOWLING, Robert T Dirksen · 2020 to 2026
$2.7M
Metabolic modulation by the HCMV UL38 geneR01AI150698 · NIAID · UNIVERSITY OF ROCHESTER · PI JOSHUA C MUNGER · 2020 to 2026
$2.4M
Impact of extracellular glutathione catabolism on triple-negative breast cancerR01CA269813 · NCI · UNIVERSITY OF ROCHESTER · PI Jeevisha Bajaj · 2022 to 2026
$2.2M
Redox Regulation of O-GlcNAcylation Signaling in the Pathogenesis of Alcoholic Fatty Liver DiseaseR01AA028859 · NIAAA · YALE UNIVERSITY · PI Ying Chen · 2022 to 2026
$1.9M
Metabolism and HCMV: determinants of the antiviral stateR01AI181865 · NIAID · UNIVERSITY OF ROCHESTER · PI JOSHUA C MUNGER · 2024 to 2026
$1.8M
Training and Research on Mechanisms of Pancreatic Cancer Associated Muscle Wasting and Related TherapiesK01CA240533 · NCI · UNIVERSITY OF ROCHESTER · PI COLE, CALVIN LLOYD · 2021 to 2025
$714k
NCI NIH HHS K01 CA240533NCI NIH HHS P30 CA076292NCI NIH HHS R01 CA269813NCI NIH HHS R37 CA230042NIAAA NIH HHS R01 AA028859NIAAA NIH HHS R24 AA022057NIAID NIH HHS R01 AI150698NIAID NIH HHS R01 AI181865NIAMS NIH HHS R01 AR078000U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA269813, R37CA230042,U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI150698Wellcome Trust 210890/Z/18/Z
6 · The paper itself

Abstract

Cells rely on antioxidants to survive. The most abundant antioxidant is glutathione (GSH). The synthesis of GSH is non-redundantly controlled by the glutamate-cysteine ligase catalytic subunit (GCLC). GSH imbalance is implicated in many diseases, but the requirement for GSH in adult tissues is unclear. To interrogate this, we have developed a series of in vivo models to induce Gclc deletion in adult animals. We find that GSH is essential to lipid abundance in vivo. GSH levels are highest in liver tissue, which is also a hub for lipid production. While the loss of GSH does not cause liver failure, it decreases lipogenic enzyme expression, circulating triglyceride levels, and fat stores. Mechanistically, we find that GSH promotes lipid abundance by repressing NRF2, a transcription factor induced by oxidative stress. These studies identify GSH as a fulcrum in the liver's balance of redox buffering and triglyceride production.

Indexed as

Glutamate-Cysteine LigaseGlutathioneLiverNF-E2-Related Factor 2TriglyceridesAnimalsLipid MetabolismLipogenesisMaleMiceMice, Inbred C57BLMice, KnockoutOxidation-ReductionOxidative StressGlutamate-Cysteine LigaseGlutathioneNfe2l2 protein, mouseNF-E2-Related Factor 2Triglycerides

Identifiers

PMID39034312
PMCPMC11271484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.